Modulation of Kinin B1 but not B2 receptors-mediated rat paw edema by IL-1β and TNFα

Peptides

Volumn 19, Issue 7, 1998, Pages 1269-1276

  Campos, Maria M ^a   Souza, Glória E p ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Faculty of Pharmaceutical Sciences   (Brazil)

Author keywords

B1 and B2 kinin receptors; B1 receptor up regulation; Cyclo oxygenase pathway; Cytokines; Glucocorticoids; Rat paw edema

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ[1-8]; CYCLOHEXIMIDE; DEXAMETHASONE; INDOMETACIN; INTERLEUKIN 1BETA; KININ; MELOXICAM; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; BRADYKININ; BRADYKININ RECEPTOR; DRUG DERIVATIVE; INTERLEUKIN 1; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; EDEMA; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HINDLIMB; INJECTION; MALE; METABOLISM; RAT; UPREGULATION; WISTAR RAT;

ANIMALS; BRADYKININ; CYCLOHEXIMIDE; CYCLOOXYGENASE INHIBITORS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HINDLIMB; INJECTIONS; INTERLEUKIN-1; MALE; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0031615474     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00087-4     Document Type: Article

References (35)

1. 1 receptors in the polymorphonuclear leucocyte accumulation induced by IL-1β in vivo in the mouse. J. Immunol. 156:1996;269-274.
2. Bathon J.M., Manning D.C., Goldman D.W., Towns M.C., Proud D. Regulation of kinin receptors on human synovial cells and up-regulation of receptor number by IL-1. J. Pharmacol. Exp. Ther. 260:1992;384-392.
3. Bhoola K.D., Figueroa C.D., Worthy K. Biorregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1992;1-80.
4. 9-bradykinin in vitro and in vivo. Br. J. Pharmacol. 92:1987;257-264.
5. 2 in 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA. 85:1988;6306-6309.
6. Burch R.M., Connor J.R., Tiffany C.W. Molecular biology and pharmacology of bradykinin receptors. Agents Actions. 27:1989;258-260.
7. Burch, R. M.; Kyle, D. J.; Stormenn, T. M. Molecular biology and pharmacology of bradykinin receptors. Burch, R. M., Ed. Austin: G. Landes Co.; 1993.
8. Burch R.M., Tiffany C.W. TNF amplification of arachidonic acid metabolism in responses to IL-1, bradykinin, and other agonists. J. Cell Physiol. 141:1989;85-89.
9. Burch R.M., White M.F., Connor J.R. IL-1 stimulates prostaglandin synthesis and cyclic AMP accumulation in Swiss 3T3 fibroblasts: interaction between two second messenger systems. J. Cell. Physiol. 139:1989;29-33.
10. Calixto J.B., Medeiros Y.S. Characterization of bradykinin mediating pertussis-toxin-insensitive biphasic responses in circular muscle of the isolated guinea pig ileum. J. Pharmacol. Exp. Ther. 259:1991;659-665.
11. 2 receptors in bradykinin-induced rat paw oedema. Br. J. Pharmacol. 114:1995;1005-1013.
12. 2 receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG). Br. J. Pharmacol. 120:1997;502-508.
13. 1 receptors mediating paw oedema and formalin induced-nociception. Modulation by glucocorticoids. Can. J. Physiol. Pharmacol. 73:1995;812-819.
14. 9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br. J. Pharmacol. 117:1996;793-798.
15. 9-bradykinin-mediated hyperalgesia in the rat paw by inflammatory stimuli. Braz. J. Med. Biol. Res. 27:1994;1793-1802.
16. 1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat. Neuropharmacology. 33:1994;127-133.
17. 9-Bradykinin. Br. J. Pharmacol. 93:1988;969-977.
18. 9-bradykinin: possible role of IL-1. Br. J. Pharmacol. 103:1991;314-315.
19. Dray A., Perkins M.N. Bradykinin and inflammatory pain. Trends Neurosci. 16:1993;99-104.
20. Ferreira S.H., Lorenzetti B.B., Poole S. Bradykinin initiates cytokine inflammatory hyperalgesia. Br. J. Pharmacol. 110:1993;1227-1231.
21. Gaginella T.S., Kachur J.F. Kinin mediators of intestinal secretion. Am. J. Physiol. 256:1989;G1-G15.
22. Hall J.M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56:1992;131-190.
23. Hall J.M. The pharmacology and immunopharmacology of kinin receptors. Farmer S.G. The kinin system. 1997;9-43 Academic Press, New York.
24. 2 bradykinin receptors. Mol. Pharmacol. 45:1994;1-8.
25. 1 receptors: a review. Immunopharmacology. 30:1995;1-26.
26. Marceau F., St-Pierre S., Regoli D. Kinin receptors in experimental inflammation. Can J. Physiol. Pharmacol. 58:1980;536-542.
27. 2 bradykinin receptor. Proc. Natl. Acad. Sci. USA. 88:1991;7724-7728.
28. 1 bradykinin receptor. J. Biol. Chem. 269:1994;21583-21586.
29. 8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain. 53:1993;191-197.
30. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol. 110:1993;1441-1444.
31. 2 receptor mechanisms and cytokine-induced hyperalgesia in the rat. Can. J. Physiol. Pharmacol. 73:1995;832-836.
32. 1 receptor gene. Biochem. Biophys. 220:1996;219-225.
33. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
34. Tiffany C.W., Burch R.M. Bradykinin stimulates TNF and IL-1 release from macrophages. FEBS Lett. 247:1989;189-192.
35. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 6:1993;109.